The findings from a new clinical trial released Wednesday may point the way to an elusive goal: a safe and effective drug that helps reduce obesity in people.
</
Categories obesity, diabetes, type 2 diabetes, health medical pharma, clinical medicine, semaglutide, bariatric surgery, body shape, glucagon like peptide 1, hospitality recreation, anti diabetic drugs, branches of biology, medical specialties, peptide hormones
